Anderson Kenneth Carl
SEC insider (Form 3/4/5 filer). CIK 0001824862. Director at C4 Therapeutics, Inc. (CCCC). 12 reported Form 4/5 transactions since Sep 2024; latest on Oct 1, 2026. Located in WATERTOWN, MA.
Companies Anderson Kenneth Carl has filed insider reports for
- C4 Therapeutics, Inc. (CCCC): Director
Anderson Kenneth Carl
CIK: 0001824862
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
C4 Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Oct 1, 2026CCCC
C4 Therapeutics, Inc.
AwardDirect3.7K shares at avg. $3.14$11K - Jul 1, 2026CCCC
C4 Therapeutics, Inc.
AwardDirect2.7K shares at avg. $4.34$12K - Jun 24, 2026CCCC
C4 Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
62K shares- - Jun 1, 2026CCCC
C4 Therapeutics, Inc.
ExerciseDirect1.1K shares at avg. $2.11$2K - Apr 1, 2026CCCC
C4 Therapeutics, Inc.
AwardDirect4.3K shares at avg. $2.70$11K - Jan 2, 2026CCCC
C4 Therapeutics, Inc.
AwardDirect6K shares at avg. $1.93$11K - Oct 1, 2025CCCC
C4 Therapeutics, Inc.
AwardDirect5.3K shares at avg. $2.15$12K - Jul 1, 2025CCCC
C4 Therapeutics, Inc.
AwardDirect7.6K shares at avg. $1.51$12K - Jun 18, 2025CCCC
C4 Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
35.5K shares- - Apr 1, 2025CCCC
C4 Therapeutics, Inc.
AwardDirect7.8K shares at avg. $1.44$11K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 1, 2026 | CCCC C4 Therapeutics, Inc. | Award | 3,662 | $3.14 | $11,499 | Direct |
| Jul 1, 2026 | CCCC C4 Therapeutics, Inc. | Award | 2,650 | $4.34 | $11,501 | Direct |
| Jun 24, 2026 | CCCC C4 Therapeutics, Inc. | Award Stock Option (Right to Buy) | 62,000 | - | - | Direct |
| Jun 1, 2026 | CCCC C4 Therapeutics, Inc. | Exercise | 1,070 | $2.11 | $2,258 | Direct |
| Apr 1, 2026 | CCCC C4 Therapeutics, Inc. | Award | 4,259 | $2.70 | $11,499 | Direct |
| Jan 2, 2026 | CCCC C4 Therapeutics, Inc. | Award | 5,958 | $1.93 | $11,499 | Direct |
| Oct 1, 2025 | CCCC C4 Therapeutics, Inc. | Award | 5,349 | $2.15 | $11,500 | Direct |
| Jul 1, 2025 | CCCC C4 Therapeutics, Inc. | Award | 7,616 | $1.51 | $11,500 | Direct |
| Jun 18, 2025 | CCCC C4 Therapeutics, Inc. | Award Stock Option (Right to Buy) | 35,500 | - | - | Direct |
| Apr 1, 2025 | CCCC C4 Therapeutics, Inc. | Award | 7,841 | $1.44 | $11,252 | Direct |
1-10 of 12 transactions